Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Aug 4;17(8):e89316.
doi: 10.7759/cureus.89316. eCollection 2025 Aug.

Relief of Suspected IgA Vasculitis-Associated Enterocolitis Manifested as Severe Diarrhea and Hypoalbuminemia Treated With Glucocorticoid Therapy and Administration of Fibrogammin® (Purified Coagulation Factor XIII Concentrate): A Case Report

Affiliations
Case Reports

Relief of Suspected IgA Vasculitis-Associated Enterocolitis Manifested as Severe Diarrhea and Hypoalbuminemia Treated With Glucocorticoid Therapy and Administration of Fibrogammin® (Purified Coagulation Factor XIII Concentrate): A Case Report

Takashi Aikawa et al. Cureus. .

Abstract

A 62-year-old female was admitted to our hospital with abdominal pain, diarrhea, and bloody stool. She suffered from severe diarrhea 30 times per day and consequently got hypoalbuminemia and hyponatremia. Esophagogastroduodenoscopy and total colonoscopy showed diffuse erosion of the duodenum, terminal ileum, and colorectum. Her endoscopic findings were similar to the former case reports of immunoglobulin A (IgA) vasculitis-associated enterocolitis. Further investigation of biopsy demonstrated that IgA-positive lymphocytes invaded the perivascular of the submucosal layer. However, we did not find IgA deposition in the capillary wall, and no granuloma, basal plasma cytosis, or crypt abscess was detected. Although a definite diagnosis could not be established, we considered the possibility of refractory IgA vasculitis-associated enterocolitis and initiated glucocorticoid therapy and administration of Fibrogammin® (purified coagulation factor XIII concentrate). The patient's diarrhea improved within one and a half months after admission.

Keywords: coagulation factor xiii activity; enterocolitis; fibrogammin; immunoglobulin a vasculitis; intractable diarrhea.

PubMed Disclaimer

Conflict of interest statement

Human subjects: Informed consent for treatment and open access publication was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Figures

Figure 1
Figure 1. CT on admission
Abdominal CT showing thickened wall of the transverse part of duodenum and proximal jejunum (a, blue arrowheads), ascending colon (b, yellow arrow), transverse colon (c, yellow arrow), and sigmoid colon (d, yellow arrow).
Figure 2
Figure 2. Total colonoscopy on day 14 after admission
(a) The terminal ileum. (b-d) The colon. There was loss of the villi in the terminal ileum. There were small islands of the remaining villi in the terminal ileum (a, yellow arrowheads). There were a couple of round redness similar to hematoma-like protrusion in the colon (b, green arrowheads). In the colon, there were small islands, which looked alike shapes in the terminal ileum (c, d, blue arrowheads).
Figure 3
Figure 3. Esophagogastroduodenoscopy on day 22 after admission
(a) The stomach. (b-d) The descending part of the duodenum. There was mucosal erythema in the stomach. There were small islands of the remaining villi in the duodenum (b, yellow arrowheads). Those islands were more clearly observed with narrow band imaging (d) than with white light (c).
Figure 4
Figure 4. Specimens of mucosal biopsy with hematoxylin and eosin stain
(a, b) Specimens of the terminal ileum. (c, d) Specimens of the colon. (e, f) Specimens of the duodenum. Photomicrograph of biopsy from the ileal, colonic, and duodenal lesions showed inflammatory cell infiltrated submucosa, red blood cells leaked around vessels, and leukocytoclastic vasculitis with nuclear dusts (a, c, e). There were IgA-positive lymphocytes gathering around the blood vessels in the submucosa of the ileum and duodenum (b, d, f).
Figure 5
Figure 5. Clinical course after hospitalization
Figure 6
Figure 6. Endoscopic findings of total colonoscopy on day 35 after admission
(a) Terminal ileum. (b) The cecum. (c. d) The colon. Findings showed that the area of the ulcer had reduced, and some areas of the colorectum were healed moderately.
Figure 7
Figure 7. Endoscopic findings of esophagogastroduodenoscopy on day 49 after admission
(a) The Stomach. (b-d) The duodenum. Findings demonstrated the disappearance of erythema and regeneration of the duodenal villi.

Similar articles

References

    1. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Jennette JC, Falk RJ, Bacon PA, et al. Arthritis Rheum. 2013;65:1–11. - PubMed
    1. GI involvement in Henoch-Schönlein purpura. Esaki M, Matsumoto T, Nakamura S, et al. Gastrointest Endosc. 2002;56:920–923. - PubMed
    1. Immunoglobulin A vasculitis without purpura in an elderly female patient: a case report. Murata M, Yamazaki Y, Shimogama T, Ota Y, Moriyoshi K, Miyamoto S. Clin J Gastroenterol. 2021;14:1090–1095. - PubMed
    1. Duodenojejunitis: is it idiopathic or is it Henoch-Schönlein purpura without the purpura? Gunasekaran TS, Berman J, Gonzalez M. J Pediatr Gastroenterol Nutr. 2000;30:22–28. - PubMed
    1. Purpura-free small intestinal IgA vasculitis complicated by cytomegalovirus reactivation. Matsumura M, Komeda Y, Watanabe T, Kudo M. BMJ Case Rep. 2020;13:0. - PMC - PubMed

Publication types

LinkOut - more resources